BackTaro Pharmaceutical Industries Overview

Taro Pharmaceutical Industries Other Current Assets

Latest other current assets for TARO: $42M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$41.77M
4177300.00% YoYΔ $41.77M vs prior year quarter

Peer average / median

Loading

Taro Pharmaceutical Industries Other Current Assets History

Loading

Taro Pharmaceutical Industries vs. peers: Other Current Assets Comparison

Loading

Taro Pharmaceutical Industries Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Taro Pharmaceutical Industries (TARO) FAQ

Taro Pharmaceutical Industries (TARO) currently reports a other current assets of $42M as of March 2024. That compares with $-1K in the prior-year period — up 4177300.0% year over year. Use the charts on this page to explore Taro Pharmaceutical Industries's other current assets history and peer comparisons.

Taro Pharmaceutical Industries's other current assets increased from $-1K to $42M — a 4177300.0% year-over-year increase (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Taro Pharmaceutical Industries reported $42M in other current assets as of March 2024. That compares with $-1K in the prior-year period — up 4177300.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $42M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Taro Pharmaceutical Industries, and consider following TARO for alerts when major investors trade the stock.

Taro Pharmaceutical Industries is classified in the Healthcare sector. On other current assets, it currently shows $42M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TARO with unrelated industries.